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Abstract
The 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) enzymes catalyze
sequential metabolic reactions in the folate biosynthetic pathway of bacteria and lower eukaryotes. Both enzymes represent
validated targets for the development of novel anti-microbial therapies. We report herein that the genes which encode
FtHPPK and
FtDHPS from the biowarfare agent Francisella tularensis are fused into a single polypeptide. The potential of
simultaneously targeting both modules with pterin binding inhibitors prompted us to characterize the molecular details of
the multifunctional complex. Our high resolution crystallographic analyses reveal the structural organization between
FtHPPK and
FtDHPS which are tethered together by a short linker. Additional structural analyses of substrate complexes
reveal that the active sites of each module are virtually indistinguishable from those of the monofunctional enzymes. The
fused bifunctional enzyme therefore represents an excellent vehicle for finding inhibitors that engage the pterin binding
pockets of both modules that have entirely different architectures. To demonstrate that this approach has the potential of
producing novel two-hit inhibitors of the folate pathway, we identify and structurally characterize a fragment-like molecule
that simultaneously engages both active sites. Our study provides a molecular framework to study the enzyme mechanisms
of HPPK and DHPS, and to design novel and much needed therapeutic compounds to treat infectious diseases.
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Introduction
Tetrahydrofolate is an essential cofactor required for metabolic
reactions involving one-carbon transfer. Most notably, it is
required for the synthesis of the nucleic acid precursors purines
and thymidine, the amino acids methionine and glycine, and
pantothenate [1]. Higher organisms derive folate from their diet
[2] and lack the necessary enzymes for folate synthesis, but almost
all eubacteria and a number of lower eukaryotes including the
pathogens Plasmodium falciparum and Pneumocystis carinii (jirovecii)
synthesize tetrahydrofolate. The folate pathway is therefore an
ideal target for anti-infectives. The sulfonamide drugs, which
target the enzyme dihydropteroate synthase (DHPS) in the
pathway, have remained important clinical agents since they were
first discovered in the 1930s [3]. The folic acid pathway is also an
important target for cancer therapy because the enzyme
dihydrofolate reductase (DHFR) is the final enzyme in the
pathway and is present in higher organisms to process dietary
folate and to recycle oxidized forms of tetrahydrofolate. DHFR
inhibitors such as methotrexate are potent anti-cancer agents that
block nucleic acid synthesis in cancer cells [4]. Inhibiting two steps
in a metabolic pathway is a particularly effective therapeutic
strategy that provides a synergistic double hit, and sulfonamides in
conjunction with the bacterial selective DHFR inhibitor trimeth-
oprim have proven to be a potent and broad spectrum
antibacterial cocktail that is commonly prescribed [5].
DHPS acts at a crucial convergence point in the folate pathway,
and catalyzes the condensation of p-aminobenzoic acid (pABA)
and 6-hydroxymethyl-7,8–dihydropterin-pyrophosphate (DHPPP)
to form the intermediate dihydropteroate (Fig. 1). The sulfon-
amides act by mimicking pABA, but their efficacy has been
severely impacted by drug resistance which began to emerge
shortly after they were first introduced into the clinic [6,7,8].
However, these orally bioavailable drugs remain useful against a
number of pathogenic organisms, most notably, methicillin
resistant Stapholoccus aureus (MRSA) and Pneumocystis carinii (jirovecii)
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14165[9,10]. To address the problem of resistance and to continue
taking advantage of this valuable broad spectrum antibacterial
drug target, we are investigating a new class of DHPS inhibitors
that specifically bind within the pterin-binding pocket of the active
site that is structurally distinct from the pABA-binding site.
Our focus is on the enzymes from three category A biowarfare
agents: Bacillus anthracis (anthrax), Francisella tularensis (tularemia)
and Yersinia pestis (plague). We described the structure of the B.
anthracis enzyme several years ago [11] and recently reported a
series of pterin-based inhibitors of the enzyme [12]. Here, we
report the structure of the F. tularensis enzyme and show that it is
fused to 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase
(
FtHPPK) which catalyzes the previous step in the pathway (Fig. 1).
This was initially revealed by searching the F. tularensis genome for
the DHPS gene and identifying it within an open reading frame
that includes the HPPK gene. The structure reveals the molecular
organization of the resulting bifunctional enzyme, and we also
demonstrate that each active site binds substrate in the same
manner observed in the monofunctional forms. However, we also
show that the distinct pterin-binding pockets of each module can
each accommodate one of the pterin-based inhibitors that we have
previously identified [12]. This has two important consequences
for our drug discovery efforts. First, HPPK is revealed as a valid
additional target for developing pterin-based folate inhibitors that
can potentially block two sequential steps in the pathway. Second,
the F. tularensis
FtHPPK-DHPS bifunctional enzyme provides a
convenient vehicle for identifying and developing such agents.
Results
Discovery of the fused gene encoding
FtHPPK-DHPS
When this project was initiated, the F. tularensis LVS genome was
incomplete and unannotated, and the partially sequenced genome
was received in the form of 37 contigs from the Swedish Defense
Research Agency. The complete sequence has since been
published [13]. The sequences were analyzed using a combination
of programs within the GCG software suite (Accelrys Software Inc.
San Diego, CA), EMBOSS (The Sanger Center, Hinxton, UK),
and NCBI (Bethesda, MD). Synteny was identified through
alignment with the DHPS enzyme from B. anthracis which revealed
the F. tularensis DHPS gene on the antisense strand. Analysis of the
open reading frame revealed that the
FtDHPS gene is considerably
longer than the typical prokaryotic DHPS gene, and that a 59
extension encodes the
FtHPPK gene. Multiple alignments showed
that the two sequences are well conserved compared to those of
the monofunctional enzymes, particularly in the regions of the
active and substrate-binding sites (Fig. 2). However, the C-terminal
residues of the
FtDHPS module corresponding to the final a-helix
of the TIM-barrel structure is missing, and it was of particular
interest to understand how the structure would accommodate this
missing a-helix and whether it had any functional consequences.
FtHPPK-DHPS Apo Structure
FtHPPK-DHPS crystallized in space group P1 with two
molecules in the unit cell, and the structure was determined to
2.2 A ˚ using molecular replacement methods (Table 1; Protein
Data Bank accession code 3MCM). Size-exclusion chromatogra-
phy suggested that the enzyme is a monomer in solution (data not
shown) and that the crystallographic dimer is unlikely to have any
functional significance. To confirm this, we further characterized
the protein in solution by analytical ultracentrifugation, specifically
using sedimentation velocity and equilibrium analysis assays. Both
experiments showed that
FtHPPK-DHPS exists mainly as a
monomer in solution (Fig. 3), and there are no dimers observed
in the c(s) distribution profile (Fig. 3a) at the concentration used.
The standard sedimentation coefficient (s20,w) obtained from the
analysis (3.41S) corresponds to a molar mass of 53,000 Da, close to
the theoretical monomer molecular mass of 50,509 Da for this
protein. The weight-average frictional ratio value (f/f0)w obtained
from the analysis (1.39) reflects a slightly elongated globular
Figure 1. Schematic of the pyrophosphokinase (HPPK) and dihydropteroate synthase (DHPS) catalyzed reactions within the folate
biosynthetic pathway. The HPPK module first uses ATP to convert 6-hydroxymethyl-7,8–dihydropterin (DHP) to 6-hydroxymethyl-7,8–
dihydropterin-pyrophosphate (DHPPP) with the release of AMP, and the DHPS module then combines DHPPP with p-aminobenzoic acid (pABA) to
generate dihydropteroate (DHPteroate) with the release of pyrophosphate. The pterin-ring atoms are labeled on the DHP substrate.
doi:10.1371/journal.pone.0014165.g001
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below. It was possible to detect a weak monomer-dimer
association in solution that may explain the dimer observed in
the crystal structure. The dissociation equilibrium constant (KD)o f
the monomer-dimer self-association model determined from the
equilibrium data was 2.7 mM (Fig. 3b).
An overview of the structure is shown in Figure 4A. The N-
terminal
FtHPPK module is connected to the C-terminal
FtDHPS
Figure 2. The primary structure of the HPPK-DHPS bifunctional enzyme from Francisella tularensis and its homology to other HPPK
and DHPS enzymes. The organisms shown are Francisella tularensis (Ft), Saccharomyces cerevisiae (Sc), Yersinia pestis (Yp), Escherichia coli (Ec) and
Bacillus anthracis (Ba), and numbering is with respect to the Ft enzyme. Secondary structure elements and key structural regions are labeled
according to Fig. 3A. Strictly conserved regions are blocked in red, and conserved regions are boxed. Important loop regions are highlighted and
labeled according to their domain association. (A) Multiple sequence alignment of the HPPK module. Residues that contribute to substrate binding
are shown as blue triangles. The conserved motif that binds Mg
2+ is shown as gray circles within blue triangles. (B) Alignment of the DHPS module.
The inter-domain linker regions of F. tularensis and S. cerevisiae are highlighted in green and the corresponding b-hairpin of monofunctional DHPS is
highlighted in orange. Residues that interact with substrates are indicated as purple triangles. Residues known to contribute to sulfonamide drug
resistance are indicated by red circles. The missing Da8 helix at the C-terminus is highlighted in purple. Sequence alignments were performed using
ClustalW [39] and analyzed using ESPript2.2 [54].
doi:10.1371/journal.pone.0014165.g002
Table 1. Data Collection and Refinement Statistics.
Apoenzyme Substrate Complex Compound 1 Complex
Data collection
Space group P1 P1 P1
Cell dimensions
a, b, c (A ˚) 43.0, 58.1, 105.7 42.5, 58.5, 109.3 42.9, 58.2, 105.1
a, b, c (u) 91.3, 99.3, 111.6 82.0, 81.0, 68.1 91.0, 80.1, 68.3
Resolution (A ˚)3 8 . 6 22.2 (2.2822.2)* 39.222.3 (2.3822.3)* 46.122.2 (2.2822.2)*
Rmerge 0.13 (0.28) 0.13 (0.30) 0.11 (0.33)
Completeness (%) 94.4 (80.1) 96.3 (84.9) 93.3 (76.4)
Redundancy 3.5 (2.9) 3.5 (2.8) 3.6 (2.8)
I/sI 23.6 (5.3) 24.8 (4.4) 21.7 (4.6)
Refinement
Total reflections 155,578 143,185 157,212
Unique reflections
Resolution (A ˚)
44,083
38.622.2
41,099
39.222.3
43,519
46.122.2
Rwork/Rfree(%)
a 20.6/25.6 26.2/30.8 21.3/25.9
No. of atoms
Protein
Water
Mg
AMPcPP
DHP
Compound 1
Average B-factor (A ˚2)
6,043
102
1
–
–
–
6,327
42
4
62
56
–
5,976
120
3
–
–
22
Protein 47.8 43.7 46.6
Water 35.8 31.5 35.2
Mg
2+ 60.2 30.8 51.5
AMPcPP – 27.3 –
DHP – 27.6 –
Compound 1 – – 53.0
Ramachandran (%)
Favored 97.4 96.2 96.2
Allowed 2.6 3.8 3.8
Outliers 0 0 0
Rmsd
Bond lengths (A ˚) 0.01 0.01 0.01
Bond angles (u) 0.9 0.96 0.74
*Data were collected from a single crystal. Values in parentheses are for the highest-resolution shell.
aRfree was calculated using 5% of the reflections.
doi:10.1371/journal.pone.0014165.t001
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module are very similar to those of the monofunctional enzymes. A
multiple sequence alignment using representative HPPK and
DHPS primary structures confirms the high degree of sequence
conservation within each module (Fig. 2). The two molecules in the
asymmetric unit are very similar (RMSD of 0.4 A ˚ on a-carbons)
and differ only in the flexible loop regions. Regions missing in the
final model due to disorder areresidues 44–56 and 89–98 withinthe
FtHPPK module, and residues 213–224, 304–318 and 354 within
the
FtDHPS. In addition, there was no observable electron density
for the N-terminal 20 residues that correspond to the His6-tag. In
the descriptions of the modules, secondary structures are numbered
accordingtothemonofunctionalenzymeswith prefixesH and D for
HPPK and DHPS, respectively (Fig. 2).
The core of the
FtHPPK module adopts the canonical aba fold
that has previously been described [14,15,16] and comprises a
central, 4-stranded antiparallel b-sheet (Hb2-Hb3-Hb1-Hb4)
flanked by four a-helices (Ha1-Ha2-Ha3-Ha4). Helices Ha1a n d
Ha2 pack against the surface of one side of the b-sheet, and Ha3
and Ha4 pack onto the other surface. The C-termini of related
monofunctional HPPKs typically end following Ha4 but the
FtHPPK module terminates in a well-ordered 10-residue inter-
domain linker that directly tethers it to
FtDHPS. The linker contains
a short, 4-residue b-strand that associates with the b-sheet of
FtHPPK. TheTIM-barrel foldof the
FtDHPS module [11,17,18,19]
contains the typical 8-stranded b-barrel (Db1-Db2-Db3-Db4-Db5-
Db6-Db7-Db8). However, as anticipated from the sequence
alignment (Fig. 2), only seven of the eight surrounding a-helices
are present (Da1-Da2-Da3-Da4-Da5-Da6-Da7) with the carboxy-
terminal Da8 helix missing. The gap in the TIM barrel is partly
filled by Lys421 and Ile422 that follow Db8 at the C-terminus, and
by the flanking helices Da1a n dD a7 that move slightly inwards to
fill the space, but there remains a significant cleft on the surface of
the TIM-barrel structure (Fig. 4B). In the E. coli and B. anthracis
DHPS structures, there is an N-terminal b-hairpin that caps the N-
terminal end of the TIM-barrel, but this is not present in the F.
tularensis structure. The
FtHPPK domain partially performs this role,
but is shifted by approximately 30u from where the b-hairpin would
typically be positioned.
FtHPPK-DHPS in Complex with HPPK Substrates
The crystal structure of
FtHPPK-DHPS in complex with the
non-hydrolyzable ATP analog (AMPcPP) and 6-hydroxymethyl-
7,8-dihydropterin (DHP) was determined at 2.3 A ˚ resolution
(Table 1; Protein Data Bank accession code 3MCO). An a-carbon
superposition shows that the overall fold of the substrate complex
closely resembles that of the apo form with an RMSD of 0.6 A ˚.
The mode of interaction of the two substrates within the
FtHPPK
active site (Fig. 5A) is virtually identical to that of previously
determined HPPK complexes [15,16,20,21,22]. Difference elec-
tron density maps clearly showed both substrates bound to the
FtHPPK module, and two large spheres of density within the ATP
binding pocket were interpreted and successfully refined as Mg
2+
ions (Fig. 5B). The HPPK mechanism involves three flexible loops,
HLp1, HLp2 and HLp3 in our structure, that undergo large
conformational changes and adopt more stable structures in the
presence of the two substrates [20,23,24,25]. Lys44, Ala45 and
Val46 within HLp2 and Arg88, Trp95 and Arg98 within HLp3
make key stabilizing interactions with the two substrates.
The adenosine ring of AMPcPP packs into a cleft formed by
Leu76, Lys80, Ile104, Leu117, Thr118 and His121, and the
triphosphate moiety is coordinated by the two Mg
2+ ions bridged
between two absolutely conserved aspartate residues, Asp101 and
Asp103. In addition, there are key electrostatic interactions between
the b-a n dc-phosphates and Lys80, Arg88, Arg98, His121, and
Arg127thatarealso highlyconserved.Inoneofthemoleculesofthe
asymmetric unit in the apo structure, one Mg
2+ ion remains
coordinated between the side chains of Asp101 and Asp103 in the
absence of substrate, but the relatively high B factors of the ion and
its coordinating oxygen atoms suggest that it is weakly bound. The
ribose moiety mostly points towards solvent, although the 29-
hydroxyl is hydrogen bonded to the main-chain oxygen atom of
Lys116.TheDHPsubstratebindswithinanadjacentpocket formed
by Ser43, Val46, Asn61 and Trp95, and the pterin ring -stacks
Figure 3. Analytical ultracentrifugation of the HPPK-DHPS bifunctional enzyme from Francisella tularensis. (A) The sedimentation
velocity profiles (fringe displacement) were fitted to a continuous sedimentation coefficient distribution model c(s). The experiment was conducted
at a loading protein concentration of 0.69 mg/ml in at 20uC and at a rotor speed of 60,000 rpm. (B) Absorbance scans at 280 nm at equilibrium are
plotted versus the distance from the axis of rotation. The protein was centrifuged at 4uC for at least 24 h at each rotor speed of 15 k (red), 22 k (blue)
and 27 k (black) rpm. The solid lines represent the global nonlinear least squares best-fit of all the data sets to a monomer-dimer self-association
model with a very weak KD (2.7 mM). The loading protein concentration was 20 mM and the r.m.s. deviation for this fit was 0.0037 absorbance units.
doi:10.1371/journal.pone.0014165.g003
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Phe129. The OG oxygen of Ser43, together with the mainchain
of residues 44 and 46, provide a hydrogen bond ‘zipper’ that
specifically recognizes the ‘nitrogen face’ of the pterin ring (positions
1, 2, and 8 as defined in Fig. 1), and the side chain of Asn61 forms
hydrogen bonds tothenitrogen and carbonyl-oxygen substituents at
positions 3 and 4. Within this pocket, the 6-hydroxymethyl group of
DHP is coordinated by one of the Mg
2+ ions and appropriately
oriented towards the pyrophosphate moiety of AMPcPP for in-line
phosphoryl transfer (Fig. 5B).
We recently showed that DHP can engage the pterin-binding
pocket of the monofunctional B. anthracis enzyme and act as an
effective inhibitor [12]. It was therefore not surprising that a
second molecule of DHP was present in the pterin-binding pocket
of the DHPS module (Fig. 5C). The electron density for this
second DHP is unequivocal (Fig. 5D). We have extensively
characterized the pterin-binding pocket of DHPS and described
how the pterin ring is recognized [11,12,26], and the key residues
are conserved in the F. tularensis enzyme. These residues include
Asp210, Thr216, Asp255, Asn277, Val279, Val299, Ile301,
Asp346, Phe349, Phe351, Gly379, Lys383 and Arg418, within
the core of the TIM-barrel, which provide specific van der Waals,
hydrogen-bond and -stacking interactions. A key structural water
molecule (W2) is also present.
The Structures of the Active Site Loops in the DHPS
Module
Loops D1 and D2 in the
FtDHPS module that link the first two
ab units of the TIM barrel are highly conserved, contain sites of
sulfonamide resistance (Fig. 2) and clearly have important but
poorly defined functional roles [11]. In both molecules in the
asymmetric unit, D1 (residues 180 to 193) is folded into an
extended b-ribbon and makes a crystal contact with a neighboring
molecule via Phe189 (Fig. 5C). A similar conformation is present
in our B. anthracis DHPS structure which precludes a prediction of
its role at the active site, although a conserved aspartic acid that
has been implicated in catalysis [19] is present (Asp186). In
contrast, D2 is relatively well ordered adjacent to the active site,
and completely visible in molecule ‘B’ in the presence of DHP
substrate (Fig. 5C). Lys217, typically an arginine residue in other
DHPS enzymes, can potentially interact with the carboxyl group
of pABA or contribute to the anion-binding pocket that engages
the b-phosphate of the DHPPP substrate. This location for D2
adjacent the pABA binding site is consistent with the presence of
sulfonamide resistance mutations within this loop region. Finally,
in other DHPS structures, the loop connecting Db7 and Da7
typically contains a short two-turn a-helix, a-Loop D7, that we
have shown interacts with the carboxyl group of pABA in our B.
anthracis structure bound to pteroic acid [11]. This helix is limited
to a single turn in the F. tularensis DHPS module and terminated by
Pro384, but Lys383 and Ser385 remain well positioned to stabilize
the binding of the pABA moiety like their counterparts in B.
anthracis.
FtHPPK-DHPS bound to a DHPS inhibitor
We recently reported a series of DHPS inhibitors that target the
pterin-binding pocket using a virtual screening approach based on
our structural studies of the B. anthracis enzyme [12,26]. The goal
of these studies is to develop new antibacterial compounds that
bypass the problems of resistance associated with the sulfonamides
which target the pABA binding site of the enzyme. One of the
compounds, 2-(7-amino-1-methyl-4,5-dioxo-1,4,5,6-tetrahydorpyri-
mido[4,5-c]pyridazin-3-yl)propanoic acid (Compound 1, Fig. 6A), is a
low molecular weight fragment-like molecule that is well suited for
elaboration and further development, and it was of interest to
evaluate its binding within the F. tularensis enzyme. The crystal
structure of
FtHPPK-DHPS in complex with Compound 1 was
successfully resolved and refined to 2.2 A ˚ resolution (Table 1;
Protein Data Bank accession code 3MCN). The small molecule
binds within the pterin pocket in exactly the same way as the B.
anthracis enzyme (Fig. 6B), engaging the pterin recognition residues
Asp255, Asn277, Asp346, and Lys383 and a structural water
molecule in hydrogen bonding and electrostatic interactions, and
the guanidinium moiety of Arg418 in a -stacking interaction.
Intriguingly, Compound 1 was also found within the pterin
pocket of the
FtHPPK module (Fig. 7A). Similar to the HPPK
Figure 4. The overall structure of the HPPK-DHPS bifunctional enzyme from Francisella tularensis. (A) A stereo view of the overall fold and
domain organization showing the secondary structure elements within each module. Each element is labeled with the prefixes ‘H’ and ‘D’ to reflect
their locations in the HPPK (blue) and DHPS (purple) domains, respectively. The N- and C-termini and the linker region (green) are labeled. Note that
helix Da8 in the canonical DHPS TIM-barrel is missing. (B) A surface representation of the view shown in (A) that highlights the position of the domain
linker and the cleft within the DHPS module corresponding to the missing Da8 TIM-barrel a-helix.
doi:10.1371/journal.pone.0014165.g004
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FtHPPK and
FtDHPS modules bound to substrates. (A) Stereo view of the
FtHPPK module showing the detailed interactions with
AMPcPP and DHP. Both substrates are covered with transparent molecular surfaces and gray dashed lines indicate putative hydrogen-bond
interactions. Residues that contribute to substrate binding are labeled and shown in blue sticks. The inter-domain linker is colored green and a
dashed line indicates the position of the carboxy-terminal
FtDHPS module. (B) Electron densities for the nucleotide analog AMPcPP (purple) and DHP
(yellow) bound to the HPPK module. Two Mg
2+ ions (gray spheres labeled Mg1 and Mg2), and an active site water (red sphere labeled W1) are also
shown. The arrow indicates how the 6-hydroxymethyl group of DHP is appropriately oriented towards the pyrophosphate moiety of AMPcPP for in-
line phosphoryl transfer. (C) Stereo view of the interactions between DHP and the
FtDHPS module. DHP is bound within the TIM-barrel (light pink, b-
barrel), and the residues that mediate the interaction are labeled and shown in pink sticks. Three structural water molecules are shown as red spheres
and are labeled W2, W3 and W4. The location of the
FtHPPK module is indicated by a dashed line that extends from the inter-domain linker (green).
(D) Electron density for the molecule of DHP (yellow) which bound in the pterin pocket of the
FtDHPS module. In (B) and (D), the Fo-Fc simulated-
annealing omit electron densities are contoured at 3.5 s.
doi:10.1371/journal.pone.0014165.g005
Figure 6. Interaction of the
FtDHPS module with Compound 1. (A) Schematic comparison between the scaffolds of Compound 1 and DHP-PP.
Compound 1 comprises a pterin-like core and is missing half of the B-ring as highlighted in orange. (B) Stereo view of Compound 1 (orange) bound
within the pterin pocket of the TIM-barrel. Residues that make van der Waals and hydrogen-bond contacts are labeled and shown as pink sticks. The
Fo-Fc simulated-annealing omit electron density for Compound 1 is shown as a blue mesh contoured at 3.5 s.
doi:10.1371/journal.pone.0014165.g006
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stacks between the conserved phenylalanine side-chains (Phe59
and Phe129) and forms a hydrogen bonding interaction with
Asn61. However, comparing the ‘nitrogen faces’ of Compound 1
and DHP that dictate their similar binding to the DHP pocket, a
rotation of ,40u is revealed which orients the nitro moiety
proximal to the Mg
2+ ion within the divalent metal binding site
(Fig. 7B). To accommodate the molecule, the Mg
2+ ion is shifted
nearly 4 A ˚, presumably to coordinate the partial negative charge
associated with the nitro group. A consequence of this rotation is
that the ‘nitrogen face’ does not directly engage residues 43–47 but
instead interacts with loop H2 via a water molecule that occupies
this void. Also, the side chain of Asp101 can engage Compound 1
via two equally populated orientations. Finally, in the absence of
AMPcPP, residues 89–96 in loop H3 remain disordered, and
Trp95 does not enclose the pterin pocket. Thus, while Compound
1 closely mimics the binding of substrate in the
FtDHPS module, it
only partially mimics substrate binding in the
FtHPPK module.
Discussion
Comparison with monofunctional HPPK and DHPS
enzymes
To date, the structures of HPPK and DHPS from eubacteria
have revealed monofunctional enzymes, and our discovery that the
two activities are fused into a single polypeptide in F. tularensis is
therefore somewhat surprising. Nevertheless, a comparison of the
fused enzyme with its monofunctional counterparts reveals close
similarities and common active sites. The structure of HPPK has
been determined to very high resolution in its substrate-bound
form [21], and the catalytic mechanism is well understood and
supported by extensive kinetic and mutagenesis data
[22,27,28,29,30]. The canonical aba fold of the
FtHPPK module
is particularly well conserved and incorporates three conserved
loop regions, HLp1, HLp2 and HLp3, which are centrally
involved in substrate binding (Fig. 5A). In the substrate-bound
state, where these active site loops are well structured, the
FtHPPK
core can be superimposed on the E. coli and Y. pestis enzymes with
,1.5 A ˚ RMSD. A total of 13 residues were identified as being
absolutely conserved for structural and catalytic reasons [20] and
two of these are aromatic residues that clamp the pterin ring of the
DHP substrate. HLp2 is slightly larger in
FtHPPK and locally
organized by Trp55 that spatially replaces Gln50 of the E. coli
enzyme. Similar to other HPPKs, the three loops help to stabilize
the interaction of substrates via an intricate hydrogen-bonding
network, and two essential catalytic Mg
2+ ions coordinate the
phosphate groups of ATP and the nucleophilic hydroxyl group of
DHP. The most significant difference in the
FtHPPK module
occurs at the C-terminus that contains the linker region to the
FtDHPS module.
The TIM-barrel fold of the
FtDHPS module is also structurally
well conserved, and can be superimposed (a-carbon) on our B.
anthracis DHPS structure with an RMSD of 1.9 A ˚. Although the
DHPS catalytic mechanism has yet to be fully elucidated, the key
catalytic and substrate binding residues that have been identified
[11] are all present. These include residues that define the pterin-
binding pocket and others within the two flexible loops DLp1 and
DLp2 that are proposed to close over the active site locale [11].
However, there are several significant differences. Most notable is
the absence of the eighth TIM-barrel a-helix located at the C-
terminus. This is curious because the deletion creates a cleft in the
FtDHPS module that would be predicted to destabilize the TIM-
barrel. Functionally, the missing a-helix is unimportant, but it is
part of the dimer interface of the monofunctional counterparts
[11]. We have unequivocally shown that the bifunctional
FtHPPK-
DHPS enzyme is monomeric, and the deletion of the a-helix may
therefore preclude dimer formation. The
FtDHPS module also
lacks an N-terminal b-ribbon that would block the interface with
FtHPPK, and its absence is apparently structural. Finally, the non-
TIM-barrel a-helix, a-loop D7, that points toward the active site is
much shorter in the
FtDHPS module, although a serine and lysine
residue that are required to interact with pABA and pterin
substrates are present [11].
A Putative Alternate Conformation
The fusion of metabolic pathway enzymes is commonly
observed in higher organisms and is exemplified by the fatty acid
synthase complex [31,32] that essentially comprises fused
eubacterial enzymes [33]. Although absent in higher eukaryotes,
the folate pathway is present in some lower eukaryotes where the
Figure 7. The
FtHPPK module bound to Compound 1. (A) Stereo view showing the interactions of Compound 1 (Cmpd 1) within the DHP
binding pocket. The orientation is the same as that shown in Fig. 5A. Putative hydrogen-bonds are indicated as gray dashes. Two water molecules
(W1 and W2) are shown as red spheres bridging between Compound 1 and loop H2. Note that the side chain of Asp101 is 50:50 in two orientations,
both of which engage Compound 1. Compound 1 is enclosed by the Fo-Fc simulated-annealing omit electron density contoured at 2.5 s (grey mesh)
and 5.0 s (royal blue). The latter indicates the most probable location of the electron-rich nitro-moiety which dictated the fit. (B) Comparison
between the binding orientations of DHP (yellow) and Compound 1. As measured with respect to their ‘nitrogen faces’, the two compounds are
rotated by ,40u. The magnesium ions in the substrate complex at the first and second positions are labeled Mg1 and Mg2, respectively, and
interaction with Compound 1 causes Mg2 to bind in a new location as indicated by the arrow.
doi:10.1371/journal.pone.0014165.g007
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HPPK-DHPS enzymes that have been characterized in many
fungi. The structure of the
ScHPPK-DHPS region from Saccharo-
myces cerevisiae has been determined [34], and although it is similar
to our
FtHPPK-DHPS structure, the linker region is much longer
(50 residues versus 13 residues) and the HPPK modules are rotated
with respect to the DHPS module by some 60u. The fusion of
modules presumably increases pathway efficiency, either by locally
concentrating sequential intermediates or, as exemplified by the
fatty acid synthase complex, directly channeling intermediates
from one active site to the next. In both the F. tularensis and S.
cerevisiae HPPK-DHPS structures, the active sites are on opposite
sides of the fused molecule and not appropriately positioned to
channel substrates. This observation is consistent with kinetic data
from a plant mitochondrial HPPK/DHPS fused enzyme which
suggest that substrate channeling does not occur although the
individual reactions are coupled [35].
However, our structure does suggest an alternate and more
stable conformation, consistent with the analytical ultracentrifu-
gation data, in which the linker region engages the cleft on the
FtDHPS module generated by the missing a-helix. If this is the
case, why are both molecules in the asymmetric unit in the same
extended conformation? Inspection of the crystal packing reveals
that the extended DLp1 loops of both
FtDHPS modules in the
asymmetric unit interact with the inter-module interfaces of their
neighbors in a very similar fashion, essentially stabilizing the
extended conformation. Without this crystal contact, the
FtHPPK-
DHPS interface is relatively small (,485 A ˚ 2 as determined by
AREAIMOL [36]). We intend to truncate loop DLp1 to
investigate new crystal forms of the enzyme that lack this crystal
contact and which might allow this putative alternate conforma-
tion to be visualized.
Pterin Pocket Inhibitors
We have recently demonstrated that the pterin pocket of DHPS
can bind an array of pterin-like molecules and represents an
attractive target for anti-folate drug discovery [12]. We have
observed the HPPK substrate DHP in the pterin pocket of the B.
anthracis enzyme and measured the IC50 at 58.4 mM [12], and our
observation that DHP can also bind within the pterin pocket of
FtDHPS is therefore not surprising. Using a linked assay in which
the active
FtHPPK module generates the unstable DHPS substrate
DHPPP from DHP, we have not been able to measure the
FtDHPS activity, and this is probably a result of the inhibition by
excess DHP. We have no reason to believe that the
FtDHPS
module is non-functional. The active and substrate-binding sites
are both intact and there is no other folP gene encoding a second
DHPS isozyme in the organism. Furthermore, a primary structure
alignment of
FtHPPK-DHPS from various F. tularensis strains
reveals a wild type sequence, and no detrimental mutations have
been acquired in the attenuated LVS strain we are using.
In contrast, the presence of the DHPS inhibitor in the pterin
pocket of
FtHPPK is very surprising and has important
implications for drug discovery. The inhibitor was specifically
identified using the DHPS pterin pocket as the target and it was
not anticipated to engage the HPPK pocket which has a very
different architecture. HPPK has long been recognized as a
potentially useful target for the development of new antibacterials
which prompted the original crystallographic analyses [14,15,16],
and we will now pursue this possibility using our panel of DHPS
pterin-like inhibitors [12]. Moreover, the F. tularensis enzyme and
its structure will facilitate studies to identify molecules that
simultaneously bind to both pockets. Antifolate cocktails such as
sulfamethoxazole/trimethoprim that inhibit DHPS and DHFR in
the folate pathway are potent and widely-used antibacterial agents.
It has been noted that a cocktail or a single agent that inhibits the
HPPK and DHPS activities could be similarly efficacious [15].
HPPK and DHPS use ordered enzyme mechanisms in which the
ATP cleft of the former or the pterin pocket of the latter is first
occupied, followed by the binding of DHP or pABA, respectively,
and both enzymes use loop conformational changes to assemble
the active site. We have shown that the flexible loops and pABA
are not required for the binding of pterin pocket inhibitors in
DHPS [12] and we now show that the same is true for HPPK with
respect to its flexible loops and ATP. This will facilitate future drug
discovery efforts with this enzyme.
Materials and Methods
Ethics Statement
N/A
Protein expression and purification
The 50 kDa,
FtHPPK-DHPS enzyme from F. tularensis LVS was
cloned and expressed using the pET28a vector containing an N-
terminal His6-tag, grown at 37uC in BL21 Escherichia coli cells,
induced with 0.5 mM IPTG at 18uC and harvested after 4 hours.
Cells were lysed and centrifuged, and the supernatant containing
soluble His6-tagged protein was passed over a nickel-nitrilotriacetic
acid (NTA) HisTrap HP affinity column (GE Healthcare).
Following elution using a linear gradient of 20 mM Tris
(pH 7.6), 500 mM NaCl, and 500 mM imidazole, relevant
fractions were verified by SDS-PAGE, pooled, and treated with
2 mM EDTA and 15 mM dithiothreitol (DTT). For crystallization
purposes, the His6-tag was left fused to
FtHPPK-DHPS. Fractions
were concentrated, filtered (0.45 mm), and further purified to
homogeneity using a Superdex 75 size exclusion column (GE
Healthcare) equilibrated with 20 mM HEPES (pH 7.5), 100 mM
NaCl, 1 mM EDTA and 0.5 mM DTT. Purified
FtHPPK-DHPS
was concentrated to 26 mg/ml, filtered (0.22 mm), aliquoted, flash
frozen in liquid nitrogen and stored at 280uC.
Crystallization and structure determination
Crystals of the apo-enzyme form of
FtHPPK-DHPS were grown
using the sitting-drop vapor diffusion method. Prior to crystalli-
zation,
FtHPPK-DHPS was diluted to 10 mg/ml in a solution that
contained 20 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM
EDTA, 1 mM DTT and 50 mM MgCl2. Initial crystals were
found by screening against the JCSG Core I-IV suites (Qiagen)
using a Phoenix robot system (Art Robbins Instruments). Further
optimization yielded diffraction quality crystals and were obtained
by mixing equal volumes of the
FtHPPK-DHPS mixture and a
precipitant solution containing 90 mM Tris (pH 8.0), 190 mM
Sodium acetate, 24% (w/v) polyethylene glycol (PEG) 4000, 17%
glycerol, and allowed to equilibrate at 18uC. Crystals appeared in
approximately 3 days and reached maximum size in about 1 week.
The presence of 17% glycerol in the reservoir solution served as a
cryo-protectant, and crystals were frozen by direct immersion in
liquid nitrogen. Substrate (1) and inhibitor (2) complexes were
obtained by soaking pre-grown crystals in (1) excess 6-hydox-
ymethyl-7,8-dihydropterin powder (DHP, Schircks Laboratories)
and 50 mM a,b-methyleneadenosine 59-triphosphate (AMPcPP,
Sigma), and (2) 2-(7-amino-1-methyl-4,5-dioxo-1,4,5,6-tetrahydorpyri-
mido[4,5-c]pyridazin-3-yl)propanoic acid (Compound 1) as a crystalline
powder due to solubility problems.
Diffraction data were collected on the SER-CAT beamline 22-
ID at the Advanced Photon Source (APS) at Argonne National
Laboratory, and processed using HKL2000 [37] (Table 1). The
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replacement (MR) using the program Phaser [38], and the
coordinates of HPPK from Y. pestis (PDB ID 2QX0) and DHPS
from B. anthracis (PDB ID 1TWW) were used as search models.
Significant editing of both models was required. The alignment of
sequences was performed using ClustalW [39], and the program
CHAINSAW [40] was used to prune non-conserved residues to
the last common atom. Homology modeling using the SWISS-
MODEL server [41] coupled with alignments of known structures
guided the strategic removal of flexible loops and helped define a
reasonable subdomain division between the
FtHPPK and
FtDHPS
modules. The bifunctional enzyme was divided into its individual
FtHPPK and
FtDHPS subdomains, searching first for the
FtDHPS
module, and the appropriate positioning of the two modules
relative to the intra-domain linkage validated our eventual MR
solution. Iterative structure refinement was carried out using a
combination of CNS1.2 [42] and REFMAC5 [43] for simulated
annealing, sigma A weighted composite omit electron density
calculations, and restrained maximum likelihood refinement. The
initial model was manually rebuilt using COOT [44]. The final
models of the apo-enzyme form, the ternary complex bound to
AMPcPP and DHP substrates, and
FtHPPK-DHPS inhibited by
Compound 1 were fully refined using restrained options within
REFMAC5 and the PHENIX software suite [45]. The data
statistics for refinement are summarized in Table 1. The molecular
coordinates and topologies of the ligands AMPcPP, DHP, and
Compound 1 were generated using either the HIcUP or
PRODRG2 [46] servers. The quality of each crystal structure
was determined using MOLPROBITY [47], and the Ramachan-
dran statistics are reported in Table 1. AREAIMOL [36] was used
to identify surface residues that interact with substrate and
inhibitor through either hydrophobic or polar contacts. Other
electrostatic and surface calculations were performed using APBS
Tools [48] and CASTp [49], respectively.
Analytical Ultracentrifugation
Experiments were carried out in a ProteomeLab XL-I analytical
ultracentrifuge with a four-hole rotor (Beckman An-60Ti) and cells
containing sapphire or quartz windows and charcoal-filled Epon
double-sector centre pieces (Beckman Coulter, Fullerton, CA).
The density and viscosity of the ultracentrifugation buffer, 20 mM
HEPES pH 7.5, 100 mM NaCl, 1 mM EDTA and 1 mM DTT
at 4 and 20uC were calculated from its composition. The partial
specific volume at 4 and 20uC and the molecular weight of the
protein was calculated based on its amino acid composition using
the software SEDNTERP [50]. All samples were dialysed against
the ultracentrifugation buffer and the dialysate was used as an
optical reference. For the sedimentation velocity experiment the
loading volume of 400 ml was identical for the reference and
sample chambers of the double-sector centrepiece. Fringe
displacement data at time intervals of 1.0 min were collected with
the Rayleigh interference system for 10 hours at a rotor speed of
60,000 rpm and analysed with SEDFIT software (www.analytica
lultracentrifugation.com) using the model for continuous sedimen-
tation coefficient distribution c(s) with deconvolution of diffusional
effects [51,52]. The sedimentation coefficient distribution c(s) was
calculated with maximum entropy regularization at a confidence
level of p=0.68 and at a resolution of sedimentation coefficients of
n=100. The positions of the meniscus and bottom, as well as time-
invariant and radial noises, were fitted. Sedimentation equilibrium
was attained at 24 h at a rotor temperature of 4uC at increasing
speeds of 15, 22 & 27 k rpm [53]. Protein at a concentration of
20 mM (120 mL) was loaded into double-sector centrepieces and
absorbance distributions recorded at 280 nm in 0.001 cm radial
intervals with 20 replicates for each point. Global least squares
modelling were performed at multiple rotor speeds with the
software SEDPHAT (www.analyticalultracentrifugation.com) us-
ing a reversible monomer-dimer self-association model as well as
the single species model [53].
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